Cell Membrane News and Research

RSS

Stabilizing mutations in SARS-CoV-2 immunogens improve vaccine design

Researchers in the United States have developed stabilized immunogens presenting the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may improve the scalability of RBD-based coronavirus vaccines.

18 May 2021

Nanotechnology and COVID-19 diagnosis and treatment

The development of nano-biosensors and nanoparticle-based vaccines and medicines has opened a new path toward better management of the coronavirus disease 2019 (COVID-19) pandemic. In a recently published article in the journal ACS Biomaterials Science & Engineering, scientists have reviewed recent advancements in nanotechnology-based diagnostic and therapeutic interventions against human coronaviruses.

17 May 2021

Researchers identify new compound that may prevent cardiac arrhythmia risk from common drugs

Dozens of commonly used drugs, including antibiotics, antinausea and anticancer medications, have a potential side effect of lengthening the electrical event that triggers contraction, creating an irregular heartbeat, or cardiac arrhythmia called acquired Long QT syndrome.

14 May 2021

Scientists identify receptor in cells that could be key to preventing cancer drug-induced hearing loss

University of Alberta scientists have identified a receptor in cells that could be key to preventing permanent hearing loss in childhood cancer survivors who are being treated with the drug cisplatin.

14 May 2021

Novel nanotechnology could change the lives of people living with cystic fibrosis

World-first nanotechnology developed by the University of South Australia could change the lives of thousands of people living with cystic fibrosis (CF) as groundbreaking research shows it can improve the effectiveness of the CF antibiotic Tobramycin, increasing its efficacy by up to 100,000-fold.

13 May 2021

New method to efficiently deliver drugs into cells

A new, patented method called Progressive Mechanoporation makes it possible to mechanically disrupt the membranes of cells for a short time period and let drugs or genes inside cells.

12 May 2021

Researchers improve method to inhibit viruses that cause childhood respiratory infections

By engineering a short chunk of protein, or peptide, that can prevent the attachment of human parainfluenza viruses to cells, researchers have improved a method in rodent models intended to help keep children healthy.

10 May 2021

Brain-targeting drug delivery with nano-scaled apoptotic bodies

Scientists from Nanjing University and University of Macau have discovered nano-scaled apoptotic bodies (ABs) as a new brain-targeting drug carrier, bringing new promise for the Parkinson's Disease as well as other brain diseases.

7 May 2021

How did SARS-CoV-2 first evolve in humans?

In a perspective article recently published in the journal Science, Hyeryun Choe and Michael Farzan from the Scripps Research Institute, USA, have described the early-stage evolution of SARS-CoV-2 in humans. They have provided a detailed overview of how early mutations in SARS-CoV-2 spike protein facilitate its adaptation in human systems.

7 May 2021

New transport system delivers large protein-based drugs into cancer cells

The ability of antibodies to recognize specific cancer cells is used in oncology to specifically target those cells with small active agents.

7 May 2021

A single archaeal enzyme can produce a spectacular range of natural and non-natural cardiolipins

Cells of all life forms are surrounded by a membrane that is made of phospholipids. One of these are the cardiolipins, which form a separate class due to their unique structure.

7 May 2021

Indian SARS-CoV-2 variant shows enhanced host cell entry and immune evasion

A study conducted by researchers in Germany has found that the B.1.617 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has emerged in India entered certain types of lung and intestine cells with slightly increased efficiency compared with the original wild-type strain.

6 May 2021

Can SARS-CoV-2’s impairment of endothelium cause vascular disease?

The study, published in the journal Circulation Research, suggests that COVID-19 is not only a respiratory disease but also a vascular disease. It highlights how the virus attacks the vascular system, causing endothelial impairment.

4 May 2021

SARS-CoV-2 spike mutations during transmission among humans and to animals

A fascinating new study discusses the 40 mutations that are seen on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein and their potential effects on viral biology.

3 May 2021

Researchers develop a nanoparticle-based formulation with anti-SARS-CoV-2 activity

A study recently published in the journal Matter has demonstrated the development and validation of a nanoparticle-based formulation, capable of completely inhibiting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection blocking the interaction between viral spike protein and host cell angiotensin-converting enzyme 2 (ACE2).

3 May 2021

Researchers suggest new approach to build a 'nanopore' biosensor for detecting specific molecules

Researchers have spent more than three decades developing and studying miniature biosensors that can identify single molecules. In five to 10 years, when such devices may become a staple in doctors' offices, they could detect molecular markers for cancer and other diseases and assess the effectiveness of drug treatment to fight those illnesses.

28 Apr 2021

Cell Membrane News and Research

Stabilizing mutations in SARS-CoV-2 immunogens improve vaccine design

Nanotechnology and COVID-19 diagnosis and treatment

Researchers identify new compound that may prevent cardiac arrhythmia risk from common drugs

Scientists identify receptor in cells that could be key to preventing cancer drug-induced hearing loss

Novel nanotechnology could change the lives of people living with cystic fibrosis

New method to efficiently deliver drugs into cells

Researchers improve method to inhibit viruses that cause childhood respiratory infections

Brain-targeting drug delivery with nano-scaled apoptotic bodies

How did SARS-CoV-2 first evolve in humans?

New transport system delivers large protein-based drugs into cancer cells

A single archaeal enzyme can produce a spectacular range of natural and non-natural cardiolipins

Indian SARS-CoV-2 variant shows enhanced host cell entry and immune evasion

Can SARS-CoV-2’s impairment of endothelium cause vascular disease?

SARS-CoV-2 spike mutations during transmission among humans and to animals

Researchers develop a nanoparticle-based formulation with anti-SARS-CoV-2 activity

Researchers suggest new approach to build a 'nanopore' biosensor for detecting specific molecules

Some heart medications may facilitate SARS-CoV-2 infection through increasing ACE2 receptor levels

People with a higher Omega-3 Index lived longer than others, study shows

Developing nanoparticles to detect and kill multi-resistant pathogens

What do we know about the origin and evolution of SARS-CoV-2?

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News